Clin2
NCT07228052Likely a fitRecruiting

Steroid shot to prevent return to the ER for asthma

Asthma

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This trial tests whether a single steroid shot given in the emergency department can help prevent your asthma symptoms from coming back and keep you from needing to return to the ER.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
182 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You came to the emergency room with an asthma attack
  • You were given steroid medicine (like prednisone) during your emergency visit
  • You were not already taking steroid pills or injections before coming to the ER
  • You are not pregnant, breastfeeding, or have heart failure or very high blood sugar (over 300)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03889743Recruiting· Phase 4
Steroid treatment to help prevent asthma after a first wheezing illness

This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.

Turku
NCT05012033Recruiting
Study how high-dose steroids move through the body

This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.

London
NCT07179952Not yet recruiting· Phase 2
Slow-release DHEA for asthma in adults

This study tests a slow-release form of the hormone DHEA as an add-on treatment for asthma. It aims to see if it can improve asthma control and reduce inflammation, possibly helping you breathe better.

NCT07456033Recruiting· Phase 3
Depemokimab for adults and teens with type 2 asthma

This study tests a new medicine called depemokimab, given as an injection, to see if it can reduce asthma attacks in people with a specific type of asthma (type 2 high). If you have had asthma for several years and have had recent attacks despite using regular inhalers, this trial might be an option for you.

Little Rock, Arkansas
NCT07396987Recruiting
Improving asthma specialist referrals for emergency room patients

This study looks at whether a new approach can help more people get connected with asthma specialists after an emergency room visit. If you have asthma and recently went to the ER, this trial may help you get expert follow-up care to better manage your condition.

Tampa, Florida
NCT07402707Recruiting· Phase 4
Dexamethasone for acute asthma in children

This trial tests if a different steroid (dexamethasone) is as good as the usual steroid for treating children with asthma attacks in the Emergency Department. It aims to make treatment easier for children.

Sheffield

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.